EQT and CPPIB last summer agreed to acquire a majority stake in Waystar in a $2.7 billion deal, leaving previous investor Bain Capital with a minority stake.
3 min read · 12 August 2020
The PE firm sees robust growth potential for AMT, fueled by the country's diabetes problem, favorable reimbursement dynamics and increasing demand across post-acute care settings.
3 min read · 11 August 2020
SPACs are more than the flavor of the month--they're here to stay.
3 min read · 06 August 2020
The SPAC route allows Cerevel to combine two transactions into a single event, all the while presenting a more educated investor base pre-IPO, a senior executive on Bain's life sciences team said.
4 min read · 05 August 2020
AEA, which snapped up a majority stake in the contact lens retailer in 2016, has engaged Morgan Stanley and Jefferies for financial advice.
2 min read · 05 August 2020
The Chicago PE firm has teamed up with Paul Jardina, who most recently served as the CEO of Onco360, an oncology-focused specialty pharmacy.
3 min read · 05 August 2020
Underscoring investor appetite in the recession-proof sector, a deal was signed only about a month after the Canadian vet-care company hit the market.
3 min read · 03 August 2020
The firm makes a bet in the recession-resilient CDMO space, all while the digital health companies it backs see an acceleration of investor interest.
4 min read · 03 August 2020
The Harris Williams-run process is targeting a narrow group of potential buyers.
2 min read · 31 July 2020
PE appetite for healthcare technology continues unabated.
3 min read · 30 July 2020
